Clinical trial
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
NCT04512430
Study timeline
Study start (actual)2020-12-02Date precision: day
Registry last updated2025-04-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
EGFR Gene Mutationunresolved
Interventions
AtezolizumabDRUG · verified · RxNorm: atezolizumab
BevacizumabDRUG · verified · RxNorm: bevacizumab
CarboplatinDRUG · verified · RxNorm: carboplatin
PemetrexedDRUG · verified · RxNorm: pemetrexed
Sponsors & collaborators
Fundación GECPlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04512430 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.